Back
Grupo Aeroportuario del Sureste SAB de CV Vs. Aligos Therapeutics Industry Stock Comparison
Sell
45
ASRMF
Grupo Aeroportuario del Sureste SAB de CV
Last Price:
25.42
Seasonality Move:
10.72%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.01
Seasonality Move:
10.65%
Sell
45
Grupo Aeroportuario del Sureste SAB de CV (ASRMF)
is a Sell
Is Grupo Aeroportuario del Sureste SAB de CV a Buy, Sell or Hold?
- The current Grupo Aeroportuario del Sureste SAB de CV [ASRMF] share price is $25.42. The Score for ASRMF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ASRMF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASRMF Stock Price Chart
What is Grupo Aeroportuario del Sureste SAB de CV's stock price today?
-
The Grupo Aeroportuario del Sureste SAB de CV share price today is $25.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASRMF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASRMF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 41.15 | Sell |
Chaikin Money Flow: | 612 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.73 - 27.73) | Sell |
Bollinger Bands (100): | (25.76 - 29.32) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.71 | Buy |
Relative Strength Index (14 RSI): | 85.17 | Buy |
Chaikin Money Flow: | 491004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.08 - 27.66) | Buy |
Bollinger Bands (100): | (7.67 - 19.61) | Buy |
ASRMF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.44 | Sell |
20-day SMA: | 26.96 | Sell |
50-day SMA: | 27.25 | Sell |
200-day SMA: | 29.57 | Sell |
8-day EMA: | 26.71 | Sell |
20-day EMA: | 26.82 | Sell |
50-day EMA: | 27.1 | Sell |
200-day EMA: | 27.99 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.48 | Buy |
20-day SMA: | 23.64 | Buy |
50-day SMA: | 14.76 | Buy |
200-day SMA: | 15.86 | Buy |
8-day EMA: | 28.77 | Buy |
20-day EMA: | 23.99 | Buy |
50-day EMA: | 18.16 | Buy |
200-day EMA: | 16.13 | Buy |
Grupo Aeroportuario del Sureste SAB de CV Earnings Growth & ASRMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Grupo Aeroportuario del Sureste SAB de CV Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |